How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 701–800 of 1,000
Alhambra-Expósito, M. R., Molina-Puerta, M. J., Prior-Sanchez, M.-I., García, G. M., Calañas-Continente, A., & Gálvez-Moreno, M. Á. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0201-7 · Cited by 4
“sensus group [18]), consisting of experts in endocrinology, diabetes education, bariatric surgery and haematology-”
BackgroundSurgical Management of Obesity
Arutchelvam, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00028-2 · Cited by 4
Xiaosong, W., Chongyu, S., Xuqi, S., Yu, P.-W., & Yongliang, Z. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03656-9 · Cited by 4
Yang, W. P., Zalin, A., Nelson, M. R., Bonanomi, G., Smellie, J., Shotliff, K., Efthimiou, E., & Greener, V. (2019) · Journal of Medical Case Reports · doi:10.1186/s13256-019-2078-8 · Cited by 4
Romero, R. J., & Colorado-Subizar, R. (2020) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2020.01.051 · Cited by 4
“e defined T2D remission according to the American Diabetes ssociation [4] as following: Partial remission included patients ith hyperglycemia below diagnostic thresholds for diabetes, at east 1 yearś duration and without active pharmacologic therapy r ongoing procedures; and complete remission included patients ith no…”
MethodGupta, R., & Kumar, S. (2021) · International Journal of Applied and Computational Mathematics · doi:10.1007/s40819-021-01001-w · Cited by 4
Sala, P., Machado, N. M., Torrinhas, R. S., Fonseca, D. C., Ferreira, B. D. A. M., Ishida, R. K., Guarda, I. F. M. S., de Moura, E. G. H., Sakai, P., Santo, M. A., et al. (2022) · Nutrition · doi:10.1016/j.nut.2022.111631 · Cited by 4
Grossesses après chirurgie bariatrique: recommandations pour la pratique clinique (groupe BARIA-MAT)
Quilliot, D., Coupaye, M., Gaborit, B., Ritz, P., Sallé, A., Castera, V., Lelièvre, B., Pigeyre, M., Rochereau, B., Taillard, V., et al. (2019) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2019.09.004 · Cited by 9
Salman, A., Salman, M. A., Said, M., Elkassar, H., Sherbiny, M. E., Youssef, A., Elbaz, M., Elmeligui, A. M., Hassan, M. B., Omar, M. G., et al. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2124446 · Cited by 4
“level of 200mg/dL, previous history of DM, and/or consumption of anti-diabetes medications [14].”
BackgroundCho, Y.-S., Park, J., Kim, J., Kim, S.-H., Kang, M. K., Huh, Y., Suh, Y., Kong, S., Park, D. J., Yang, H., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06544-z · Cited by 4
Erukulapati, R. S., Ganguri, M., Menon, A. S., Ayyagari, U., Jayapaul, M. K., Gurazada, K. C., Nalla, S., Srinath, A., Sampath, S. K., Manohar, S. P., et al. (2023) · Clinical Diabetology · doi:10.5603/dk.a2022.0061 · Cited by 6
Bikini-line Hiatal Hernia Repair (BLHHR) During Sleeve Gastrectomy
Abdelbaki, T. N. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06881-z · Cited by 5
“Complete diabetes (T2DM) remission was defined as fasting blood glucose (FBG) 100 mg/dL and/or HbA1c 6%, and partial remission was defined as FBG 126 mg/dL and/ or HbA1c 6.5%, with both conditions met while being off anti-diabetic medication [12].”
BackgroundInfluentialHauner, H., Wirth, A. G., Gola, U., Teufel, M., Zipfel, S., de Zwaan, M., Hüttl, T. P., Kramer, K. M., & Winckler, K. (2013) · Springer eBooks · doi:10.1007/978-3-642-22855-1_7 · Cited by 5
Xu, L., Yin, J., Mikami, D. J., Portenier, D. D., Zhou, X., & Mao, Z. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.013 · Cited by 4
Can Diabetes Heal?- From Observations to Perspectives
Blasi, C. (2016) · Current Diabetes Reviews · doi:10.2174/1573399811666150702125702 · Cited by 4
A 5-dimension patient education program targeting type 2 diabetes remission
Lagger, G., Correia, J. C., Fernandes, P., Sittarame, F., & Golay, A. (2018) · Education thérapeutique du patient - Therapeutic patient education · doi:10.1051/tpe/2018018 · Cited by 5
ABCD score of > 6 predicts diabetes remission following bariatric surgery
Sohal, D. S., Nain, P. S., Singh, P. P., Ahuja, A., & Singh, A. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00801-y · Cited by 4
Elrefai, M., Ibrahim, A., Abo‐Zeid, M., Ezzat, H., Abdelgawad, M., & Elgeidie, A. (2025) · International Journal of Health Sciences · doi:10.21608/ijhegy.2025.431584.1076 · Cited by 4
Predicting Outcomes and Assessing Control with Alternate Glycemic Markers
Dungan, K. M. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0192 · Cited by 4
Ramos-Levi, A. M., & Rubio, M. Á. (2017) · Diabetes Care · doi:10.2337/dc16-2403 · Cited by 4
“(2), remission rates stabilized around a more realistic 50%1 year after BS.”
BackgroundShestakova, M. V., Sklyanik, I. A., & Dedov, I. I. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh201789104-11 · Cited by 4
“Критерии ремиссии СД согласно консенсусу ADA (по [3])”
Cheng, Y., Xie, Y., Sun, W., Chen, C., Li, C., Pérez-López, F. R., Yu, Z., Yang, F., Wang, Y., & Yuan, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003894 · Cited by 3
Intelligent neural framework for modeling the lifestyle-induced remission in the type 2 diabetes
Qasim, M., Ali, H., Farooq, A., Kamran, M., Ahmad, H., Awwad, F. A. A., & Ismail, E. A. A. (2026) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2025.117841 · Cited by 3
Herrera-González, A., León, A., Rodríguez, F. M., Sepúlveda, E. M., Guilbert, L., Quiroz, O. R., Cevallos, L., & Zerrweck, C. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04920-7 · Cited by 4
“T2DM complete remission was evaluated according to the American Diabetes Association (ADA) criteria: fasting plasma glucose (FPG) < 100 mg/dL +HbA1c <6% for 1 year without medication [14].”
MethodLaparoscopic sleeve gastrectomy for treatment of type 2 diabetes mellitus in adolescents
Mostafa, M. S., Youssef, A. A., & Soliman, M. H. (2022) · Annals of Pediatric Surgery · doi:10.1186/s43159-021-00139-y · Cited by 3
Richter, L. R., Albert, B. I., Zhang, L., Ostropolets, A., Zitsman, J. L., Fennoy, I., Albers, D. J., & Hripcsak, G. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.923704 · Cited by 4
“Varying definitions of what successful glycemic outcomes mean also complicate prediction (Buse et al., 2009; Holst and Madsbad, 2021).”
BackgroundSi, Y., Zhang, H., Han, X., Liu, W., Tu, Y., Han, J., Ma, X., Bao, Y., & Yu, H. (2023) · Obesity · doi:10.1002/oby.23764 · Cited by 3
“6 mmol/L for at least 1 year in the absence of active pharmacologic therapy or ongoing procedures by the 2009 American Diabetes Association Joint Statement [22].”
BackgroundInfluentialBodyweight loss and remission of type 2 diabetes
Birkenfeld, A. L., & Bergman, M. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00373-5 · Cited by 3
Understanding Diabetes Remission
Velayutham, K., Panneerselvam, G., & Ramanathan, B. (2025) · Apollo Medicine · doi:10.1177/09760016251323727 · Cited by 4
“[16,17] The ADA’s 2025 Standards of Care in Diabetes do not specifically address diabetes remission, but the diagnostic and management recommendations could help individuals to achieve remission.”
InfluentialGhotbi, E., Bluemke, D. A., Hathaway, Q. A., Klein, J. G., Shabani, M., Akhtarkhavari, S., Barr, R. G., Bancks, M. P., Post, W. S., Budoff, M. J., et al. (2025) · European Radiology · doi:10.1007/s00330-025-11778-9 · Cited by 3
Treatment of Morbid Obesity: Intensive Lifestyle Intervention vs. Bariatric Surgery
Papamargaritis, D. (2013) · Surgery Current Research · doi:10.4172/2161-1076.1000147 · Cited by 3
“After RYGB 41-57% of patients have remission of T2DM after 1 year [32,50,51].”
Árangur magahjáveituaðgerða á Íslandi 2001-2015
Þórarinsdóttir, R., Pálmason, V., Leifsson, B. G., & Gíslason, H. (2016) · Læknablaðið · doi:10.17992/lbl.2016.10.100 · Cited by 3
Metabolic effects of bariatric surgery on type 2 diabetes mellitus
Özmen, M. M. (2017) · Laparoscopic Endoscopic Surgical Science · doi:10.14744/less.2014.77486 · Cited by 3
Ciangura, C., Gaborit, B., Sallé, A., Quilliot, D., Castera, V., Rochereau, B., Taillard, V., Cosson, E., Ritz, P., Pigeyre, M., et al. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30212-3 · Cited by 7
“[88] Buse JB, Caprio S, Cefalu WT, et al.”
BackgroundWeight Loss and Diabetes Control Following Laparoscopic Sleeve Gastrectomy
Abdelbaki, T. N., El-Sayes, I., Talha, A., & Sharaan, M. A. (2020) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2019.0680 · Cited by 3
Benaiges, D., Goday, A., Roux, J. A. F., Fitó, M., Pozo, Ó. J., Rodríguez-Morató, J., Serra, C., Pera, M., Llauradó, G., Climent, E., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037712 · Cited by 4
Remisión de diabetes tras cirugía bariátrica malabsortiva
Arnáiz, E. G., Ballesteros-Pomar, M. D., de la Maza, B. P., Roza, L. G., Bachiller, B. R., Galindo, D. E. B., Fondo, A. U., Cobo, D. A., Moreno, A. H., González-Herráez, L., et al. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.08.006 · Cited by 3
Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults
Tarazi, M. S., Touhamy, S., Tchang, B. G., & Shukla, A. P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1942841 · Cited by 4
Zhou, M., Wang, L., Zhou, L., Chang, X., & Zhu, X. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1708-3214 · Cited by 4
Pan, Y., Han, X., Kam, H., Tu, Y., Han, J., Zhang, P., Bao, Y., & Yu, H. (2022) · Obesity Surgery · doi:10.1007/s11695-022-05952-x · Cited by 3
“6 mmol/L, and nonuse of hypoglycemic treatments for at least 1 year [17].”
BackgroundBaldane, S., Çelik, M., Körez, M. K., Baldane, E. G., Yılmaz, H., Abuşoğlu, S., Kebapçılar, L., & Alptekin, H. (2022) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2022-0016 · Cited by 6
Zhang, H., Zhai, Z., Cao, K., Li, G., Wang, Z., & Han, J. (2023) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02742-y · Cited by 3
Yu, C., Wang, L., Xu, G., Chen, G., Sang, Q., Wuyun, Q., Wang, Z., Tian, C., & Zhang, N. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002718 · Cited by 3
“[18] All patients provided consent and underwent LSG, as described previously.”
MethodBariatric surgery in adults with obesity and diabetes mellitus: a network meta-analysis
Kiesswetter, E., Stadelmaier, J., Schwarzer, G., Marjanović, G., Fink, J. M., Lehane, C., Metzendorf, M., Dias, S., Schmucker, C. M., & Schwingshackl, L. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015622 · Cited by 3
Skoradal, S. A., Vesturtún, S. V., Skoradal, M., & Davidsen, A. H. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1579255 · Cited by 3
Biochemical Correlates of Bariatric-Responsive Diabetes
Faintuch, J., Yamaguchi, C. M., Dias, M. C. G., Santo, M. A., Faintuch, J. J., & Cecconello, I. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0018 · Cited by 3
Hoey, H., Mlinac, A., Tran, C.-T., & Schlaeger, C. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0230 · Cited by 3
Genezing van diabetes mellitus type 2?
Huls, M., van Dijk, M., & Boesten, M. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0040-3 · Cited by 3
Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore
Lee, P., Tham, K. W., Tan, H., & Pasupathy, S. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013138 · Cited by 3
“Using recently published consensus definitions,(18) we defined partial DM remission as HbA1c < 6.”
MethodMin, T., Prior, S. L., Caplin, S., Barry, J. D., & Stephens, J. W. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0112 · Cited by 3
“[21] Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al.”
Urbanavičius, V., Juodeikis, Ž., Dzenkeviciute, V., Galkinė, A., Petrulionienė, Ž., Šapoka, V., Brimienė, V., Vitkus, D., & Brimas, G. (2017) · Videosurgery and Other Miniinvasive Techniques · doi:10.5114/wiitm.2017.67207 · Cited by 4
“In 2009, a consensus group from the American Diabetes Association (ADA) developed a standardized definition of remission in T2DM that can be used in clinical studies [21].”
BackgroundAbed, O., Kabir, A., Jesmi, F., Janani, L., Alibeigi, P., Abdolhosseini, M., Soheilipour, F., & Pazouki, A. (2017) · Journal of Minimally Invasive Surgical Sciences · doi:10.5812/minsurgery.55991 · Cited by 3
Marrufo-Patrón, C. A., López-Rosales, F., & Hernández-Marín, J. D. (2018) · Cirugía y Cirujanos · doi:10.24875/ciru.m18000052 · Cited by 4
Ledford, C. J. W., Fulleborn, S. T., Jackson, J. T., Rogers, T., & Samar, H. (2021) · Health Expectations · doi:10.1111/hex.13245 · Cited by 3
Diniz, M. D. F. H. S., Beleigoli, A. M. R., Coelho, A. L. B., Savassi-Rocha, A. L., & Diniz, M. T. C. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.10.006 · Cited by 3
Román-Pintos, L. M., Villegas-Rivera, G., Cardona-Muñóz, E. G., Rodríguez-Carrizález, A. D., Moreno‐Ulloa, A., Rubin, N., & Miranda‐Díaz, A. G. (2018) · InTech eBooks · doi:10.5772/intechopen.72167 · Cited by 4
Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery
Besic, V., Stubbs, R. S., & Hayes, M. T. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0222-x · Cited by 3
Ramírez-Avilés, E., Espinosa, O., Amado-Galván, M., Maydón, H., Sepúlveda-Guerrero, E., & Zerrweck, C. (2017) · Cirugía y Cirujanos (English Edition) · doi:10.1016/j.circen.2017.02.011 · Cited by 2
Blackstone, R. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-39409-1_11 · Cited by 2
Durrer, C. G., Islam, H., Cen, H. H., Moya-Garzón, M. D., Lyu, X., McKelvey, S., Singer, J., Batterham, A. M., Long, J. Z., Johnson, J. D., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00807-x · Cited by 2
“Reversal and remission of T2D via nutritional interventions are now recognized as realistic outcomes for managing glycemia in people with T2D [8, 9]; however, for meaningful reversal/remission of the disease to occur, evidence of improvement in the underlying pathophysiology of T2D is needed.”
BackgroundDifferences in splicing factors may predict type 2 diabetes remission in the CORDIOPREV study
Ojeda‐Rodríguez, A., Torres-Peña, J. D., Larriva, A. P. A.-D., Rangel-Zúñiga, O. A., Podadera-Herreros, A., Boughanem, H., G-García, M. E., López-Moreno, A., Katsiki, N., Luque, R. M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111527 · Cited by 4
Pursuing remission in type 2 diabetes: Competing strategies or complementary paths?
Koufakis, T., Sarafidis, P. A., Τσάπας, Α., & Doumas, M. N. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70212 · Cited by 2
Pescari, D., Mihuta, S., Bena, A., Pui, R., Paul, C., & Stoian, D. L. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1792614 · Cited by 3
Si, Y., Tu, Y., Wang, Y., Zhang, H., Han, X., Liu, W. T., Zhang, P., Ma, X., Yu, H. Y., & Bao, Y. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08732-z · Cited by 2
“The diagnostic criteria for T2D remission were defined as HbA1c 5.7% and FPG 5.6 mmol/L (100 mg/dL) for at least one year without medication or other treatment according to the definition of complete remission of diabetes in the 2009 ADA Joint Statement [ 23].”
InfluentialUnderstanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus
Raymond, G. S., Radin, M. S., Collin, E., & Ragoli, L. (2013) · InTech eBooks · doi:10.5772/56398 · Cited by 3
“Buse et al had [20] recently defined prolonged diabetes remission as hyperglycemia that is below the diagnostic threshold for diabetes for at least five years, while on no active pharmacologic therapy for diabetes.”
on behalf of the ESINODOP trial Investigators, Trastulli, S., Desiderio, J., Grandone, I., Fontana, L., Paolini, L., Altomare, M., D’Angelo, P., Palazzi, M., Cirocchi, R., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0996-4 · Cited by 5
Prediction of Diabetes Remission after Bariatric or Metabolic Surgery
Park, J. Y. (2018) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2018.7.1.22 · Cited by 2
A cure for type 2 diabetes: fact or fiction?
Fox, C. F. (2019) · Diabetic Medicine · doi:10.1111/dme.14128 · Cited by 2
Sano, A., Seki, Y., Kasama, K., Nabekura, T., Kurokawa, Y., Ubukata, Y., Nakazawa, N., Hara, K., Sakai, M., Sohda, M., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05510-x · Cited by 2
Yi, X., Ling, J., Meng, H., Wu, L., Zhu, S., & Zhu, L. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06003-1 · Cited by 2
Grosser, F., Herrmann, S., Bretschneider, M. P., Timpel, P., Schildt, J., Bentrup, M., & Schwarz, P. E. H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221075333 · Cited by 2
Blumenfeld, O., Rosenberg, A., Friedman, Y., Susmallian, S., Keinan‐Boker, L., & Goitein, D. (2023) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2022.0063 · Cited by 2
Reoperation After Loop Duodenojejunal Bypass with Sleeve Gastrectomy: A 9-Year Experience
Huang, C., Hsin, M.-C., Patel, A. N., Katakwar, A., Patel, A. R., & Yagnik, V. D. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07348-5 · Cited by 3
“Complete and partial T2DMremission were defined based on the American Diabetes Association as hemoglobin A1c (HbA1c) 6% with fasting blood glucose (FBG) 100 mg/dl and HbA1c 6.5% with FBG 100–125 mg/dl in the absence of antidiabetic medication, respectively [15].”
InfluentialAhmadi, M. A., Ojla, M. D., Iqbal, M., Tahir, A., Nahar, N. U., Hamza, M., & Amin, H. (2025) · Cureus · doi:10.7759/cureus.86539 · Cited by 3
“…remission as FPG 100 mg/dL and HbA1c 5.7%, sustained for at least 1 year without the use of any glucose-lowering medications, and partial remission was defined as fasting glucose between 100 and 125 mg/dL and HbA1c <6.5%, sustained for at least 1 year without antidiabetic medications [16].”
InfluentialAskenasy, N. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1010723 · Cited by 2
Indicaciones de la cirugía bariátrica en sujetos con diabetes mellitus tipo 2
Vidal, J., Blanco, J., Jiménez, A., & Flores, L. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)63007-4 · Cited by 3
Interventional Diabetology: The Evolution of Diabetes Care in the XXI Century
Soni, A., Shukla, A. P., & Rubino, F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0289-1 · Cited by 2
Self-citationMetabolic Surgery for Dabetes Mellitus between Benefits and Risks
Fica, S. V. (2015) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2015.212 · Cited by 2
“that included 621 studies with 135,246 patients reported an overall remission rate of 78% among diabetic patients undergoing bariatric surgery (21).”
BackgroundCan Bariatric Surgery be Considered Standard Therapy to Treat Type 2 Diabetes?
Meyvis, K., Block, C. E. M. D., Gaal, L. F. V., Endocrinologist, & Medicine, A. P. O. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.02.86 · Cited by 2
Tančić‐Gajić, M., Vujović, S., Vukčević, M., Ivović, M., Drezgić, M., Marina, L. C., Stojanovic, M. M., Arizanović, Z., Nenezić, A., & Micić, D. (2012) · Europe PMC (PubMed Central) · Cited by 2
Une éducation thérapeutique pour tenter la rémission du diabète de type 2
Lagger, G., Sittarame, F., Chambouleyron, M., Moutet, A. L., Müller‐Pinget, S., Chevalley, C. H., Delétraz, M., Paillard, M., & Golay, A. (2016) · Education thérapeutique du patient - Therapeutic patient education · doi:10.1051/tpe/2016007 · Cited by 4
Ershova, E. V., Troshina, E. A., & Yashkov, Y. I. (2016) · Obesity and metabolism · doi:10.14341/omet2016338-44 · Cited by 2
Hillson, R. (2017) · Practical Diabetes · doi:10.1002/pdi.2087 · Cited by 2
Diabetes remission after bariatric surgery in obese patients with haemochromatosis
Phan, F., Vatier, C., Vauloup-Soupault, C., Poitou, C., Bouillot, J., Oppert, J., & Aron‐Wisnewsky, J. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.02.005 · Cited by 3
Knowledge and Perception of College Students Toward Genetic Testing for Personalized Nutrition Care
Wilkins, J. G. (2017) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 4
Validated Scoring Systems for Predicting Diabetes Remission After Bariatric Surgery
Abdelaal, M., le Roux, C. W., & Docherty, N. G. (2017) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2017.0034 · Cited by 2
Klein, P., Tyrlíková, I., Pirolli, N. H., Barber, A., Tyrlík, M., & Goldman, L. (2019) · Journal of Obesity and Chronic Diseases · doi:10.17756/jocd.2019-024 · Cited by 3
Ghaedi, H., Takesh, S., & Banitalebi, E. (2020) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2020.18 · Cited by 3
Gautam, P., Pattanshetti, S., & Rayate, N. V. (2020) · Indian Journal of Surgery · doi:10.1007/s12262-020-02657-2 · Cited by 2
de Almeida, R. R., Aidar, F. J., de Souza, M. F. C., Oliveira, V. B., Pereira, L. M. C., Oliveira, J. L. M., Silva, J. R. S., Barreto‐Filho, J. A., Vieira, D. A. D. S., Costa, I. M. N. B. D. C., et al. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100407 · Cited by 2
Time-in-range: a promising glycemic control metric for bariatric surgery
Kang, M., & Li, W. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.002 · Cited by 2
Janero, D. R. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.876988 · Cited by 2
“Although variable among studies, criteria for complete (surgical) remission of T2D generally include both evidence of normal glycemic control and discontinuation of all diabetes medications [9,16,52,54].”
BackgroundDigital Twin Intervention for Type 2 Diabetes: One-Year Outcomes of a Randomized TrialPreprint
Joshi, S., Shamanna, P., Dharmalingam, M., Vadavi, A., Keshavamurthy, A., Shah, L., KAUFMAN, F. R., Mittal, A., Bhagra, S., Liu, S., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4499693 · Cited by 3
Anohina, V. M., Семеновна, Б. Н., Yashkov, Y. I., & Orlova, A. S. (2022) · Diabetes Mellitus · doi:10.14341/dm12863 · Cited by 1
Reversion and remission are promising targets for patients with type 2 diabetes mellitus
Канорский, С. Г. (2022) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2022-3-3-7-16 · Cited by 1
Niu, L., Mu, L., Wu, R., Tong, S., Mao, Z., Yang, Y., & Yin, J. (2024) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-024-01647-7 · Cited by 1
“Complete remission was defined as achieving glycemia below the diabetic range (HbA1c in the normal range [ 6.0%], fasting glucose 5.6 mmol/L) without pharmacological intervention for at least 12 months [16].”
BackgroundMethodInfluentialAydin, M. A., Aykal, G., Gündüz, U. R., Dincer, A., Türker, A. S., Turkoglu, F., & Güler, M. (2024) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2024.115782 · Cited by 2
Taylor, M., Ng, D., Pfisterer, K. J., Cafazzo, J. A., & Sherifali, D. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000701 · Cited by 1
“Evidence that T2D can be completely or partially reversed is now challenging the traditional approach to its management [8–20].”
Clinical Characteristics of Korean Patients with Youth-Onset Type 2 Diabetes Mellitus in Remission
Shin, S., Kim, H. Y., Kim, S. Y., & Kim, J. H. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24042 · Cited by 1
Leyaro, B. J., Howie, L., Ali, A., & Carragher, R. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01956-6 · Cited by 1
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.